Which longevity peptides are best for energy and recovery?
Peptides like BPC-157, TB-500 and MOTS-c are sold online for faster recovery and more energy. This guide checks whether any of those claims have been tested in people — and for most of them, the answer is that they haven't.
No peptide sold for energy or recovery has been shown to improve either in a controlled human trial of healthy adults. Ranked on the human evidence that does exist, the order is: tesamorelin (approved, but for HIV-related abdominal fat — not energy), sermorelin (once approved, reliable growth-hormone pharmacology, one small ageing trial), then a long tail — DSIP, semax, selank — with old and contradictory trial records, and finally BPC-157, TB-500, MOTS-c, CJC-1295 and ipamorelin, whose recovery and energy claims rest entirely on animal work. The honest answer to 'which is best' is that the best-evidenced options for recovery are not peptides at all.
- BPC-157 and TB-500 — the two peptides most often sold for injury recovery — have no completed controlled human trial for that use. Everything you have read about them is rodent data.
- MOTS-c, sold as an 'exercise mimetic' for energy, has no human dosing, safety or efficacy trial. The mouse results are real; the human product is untested.
- The growth-hormone peptides (sermorelin, CJC-1295, ipamorelin) reliably raise GH in humans. None has been shown to improve recovery, energy or performance in a healthy adult; ipamorelin's one real outcome trial did not beat placebo.
- Tesamorelin is the only compound here with strong repeated Phase 3 evidence — for reducing visceral fat in HIV-associated lipodystrophy. That evidence does not transfer to energy or anti-ageing.
- For recovery and energy, the interventions with actual human evidence are sleep, protein adequacy, creatine and progressive training. A peptide clinic will rarely lead with those.
The ranking
Ranked on: the strength of controlled human evidence for any outcome, with weight given to whether that outcome has anything to do with energy or recovery. Animal data cannot raise a position. The site takes no commission on any peptide and does not link to sellers.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | Tesamorelin | Best-evidenced — for a different indication | GRADE AEstablished |
| 2 | Sermorelin | Reliable pharmacology, thin ageing evidence | GRADE BPromising |
| 3 | DSIP (delta sleep-inducing peptide) | Old trials that disagree with each other | GRADE CEarly |
| 4 | Semax and Selank | Russian prescription record, no Western review | GRADE CEarly |
| 5 | BPC-157 | No human recovery trial exists | GRADE DInsufficient or unsafe |
| 6 | TB-500 (thymosin beta-4) | Real molecule, wrong route, no trial | GRADE DInsufficient or unsafe |
| 7 | MOTS-c | Genuine biology, zero human data | GRADE DInsufficient or unsafe |
| 8 | CJC-1295 and ipamorelin | Raise GH; did not beat placebo where tested | GRADE DInsufficient or unsafe |
| 9 | AOD-9604 | Failed its own Phase 2b trial | GRADE DInsufficient or unsafe |
The only peptide here with repeated, well-designed Phase 3 trials and a current FDA approval — to reduce visceral abdominal fat in HIV-associated lipodystrophy. That is real, replicated evidence. It is not evidence for energy, recovery or anti-ageing in people without HIV, because nobody has run that trial. It ranks first on evidence quality, not on relevance to the question.
A GHRH fragment that reliably stimulates the pituitary to release growth hormone — approved for two decades for paediatric GH deficiency and diagnostic use, discontinued commercially in 2008. Today's compounded product is prescribed off-label to ageing adults on the strength of one small 1990s trial. It does what a GHRH analogue should do; whether that translates into energy or recovery in a healthy adult has not been demonstrated.
Sold for sleep, and therefore indirectly for recovery. It has small human trials dating back to the 1980s — which is more than most of this list — but the record contradicts itself on whether it improves sleep at all. Not a validated sleep aid, and not a recovery intervention.
Both are approved prescription nasal sprays in Russia — Semax for stroke recovery and cognition, Selank for anxiety — with decades of trials from a single national research network and no evaluation to FDA or EMA standards. They are sold online elsewhere as 'mental energy' nootropics. Nothing sold that way has passed a Western regulatory review, and neither has a trial in healthy adults for energy.
The most-sold recovery peptide in the world has fewer than thirty people in its entire published human record, none in a completed controlled efficacy trial. The tendon, ligament and gut-healing results are from rats. The FDA has specifically excluded it from compounding. The interesting preclinical signal is real; it is not a reason to inject an unregulated product.
Thymosin beta-4 is a legitimately studied molecule — the developer's controlled human trials are topical treatments for chronic wounds and dry eye. The injectable grey-market product sold for sports recovery has never been tested that way in a human trial. It is sold on a route of administration and for an indication that no trial has examined.
A mitochondrial-encoded peptide that acts as an exercise-like metabolic signal in mice — one of the most interesting molecules in current ageing research. Every injectable MOTS-c product sold online is extrapolated from mouse dosing with no human safety, pharmacokinetic or efficacy data. The excitement is legitimate; the human evidence does not yet exist.
The standard 'GH stack' sold for recovery and sleep. Both reliably produce a growth-hormone pulse in humans — that much is established. Ipamorelin's only real clinical-outcome trial, for post-surgical bowel recovery, did not beat placebo. CJC-1295's human record is two short pharmacokinetic studies from a company that never pursued approval. Neither is approved for any use.
A growth-hormone fragment sold for fat loss and 'metabolic energy'. Its developer took it through Phase 2b obesity trials and it failed to beat placebo on weight loss. A negative result from a sponsor-run human trial is more informative than no evidence — and it is a negative result for the exact use it is still sold for.
What the recovery claims are actually built on
Claim versus the strongest evidence behind it
| Peptide | Sold for | Strongest human evidence | Strongest evidence of any kind |
|---|---|---|---|
| BPC-157 | Tendon, ligament, gut recovery | None (no completed controlled trial) | Rat tendon and gut-healing models |
| TB-500 | Muscle and connective-tissue recovery | Topical trials for chronic wounds and dry eye | Rodent cardiac and wound models |
| MOTS-c | Energy, 'exercise in a vial' | None | Mouse exercise-capacity and metabolic studies |
| CJC-1295 / ipamorelin | Sleep, recovery, lean mass | Raises GH pulse; one outcome trial failed | Pig and rat cortisol studies |
| Sermorelin | GH restoration, recovery, sleep | Reliable GH release; one small ageing trial | Decades of approved paediatric use |
| Tesamorelin | Fat loss, energy | Repeated Phase 3 — HIV lipodystrophy only | Same |
| DSIP | Deep sleep | Small, contradictory trials since the 1980s | Same |
| Semax / Selank | Mental energy, focus | Russian trials; no Western review | Same |
What has human evidence for energy and recovery
The uncomfortable answer to the question in the title is that the best-evidenced interventions for energy and recovery are not peptides. They are the unglamorous ones a peptide clinic rarely leads with, because none of them can be sold in a vial.
Ranked ahead of every peptide above, on human trials
- Sleep duration and regularity — the single largest modifiable driver of recovery in controlled studies, and the one most peptides are indirectly trying to imitate.
- Protein adequacy — roughly 1.6 g per kilogram of body weight per day in trained adults is where the human dose-response data plateaus for muscle repair.
- Creatine monohydrate — hundreds of trials on strength, lean mass and, increasingly, cognition in older adults. Cheap, oral, and better-evidenced than any injectable on this page.
- Progressive training with planned recovery — the intervention every recovery peptide is measured against in animal models, and the one that actually has the human outcome data.
- Correcting a genuine deficiency — iron, vitamin D, B12 — where a blood test shows one. Fatigue with a measurable cause responds to the cause, not to a peptide.
Frequently asked questions
What is the best peptide for recovery?
None has been shown to improve recovery in a controlled human trial of healthy adults. BPC-157 and TB-500, the two most sold for it, have no completed controlled human trial for that use — their healing results are from rats. The best-evidenced recovery interventions in humans are sleep, adequate protein, creatine and structured training, none of which is a peptide.
Does BPC-157 work for injury recovery?
In rats, the tendon and gut-healing data are consistent and interesting. In humans, there is no completed controlled efficacy trial, fewer than thirty people in the published record, and no approved formulation — the FDA has specifically excluded it from compounding. Anyone selling it for recovery is selling ahead of the evidence.
Is MOTS-c good for energy?
MOTS-c is genuinely interesting mitochondrial biology, and in mice it improves exercise capacity and metabolic markers. No human dosing, safety or efficacy trial exists. Every injectable MOTS-c product sold online is extrapolated from mouse doses with no human data behind it.
Do growth hormone peptides like CJC-1295 and ipamorelin improve recovery?
They reliably raise growth hormone in humans — that is established. Whether the raised GH improves recovery, sleep or performance in a healthy adult has not been demonstrated, and ipamorelin's one real clinical-outcome trial did not beat placebo. Neither is approved for any use.
Which peptide has the best evidence overall?
Tesamorelin — repeated Phase 3 trials and a current FDA approval. But that evidence is for reducing visceral fat in HIV-associated lipodystrophy, not for energy, recovery or anti-ageing in the general population. Strong evidence for a narrow indication is not evidence for the reason most clinics prescribe it.
Are these peptides safe to combine with prescription medication?
Nobody can tell you with confidence, because for the unapproved compounds the human interaction data largely does not exist. That absence is itself a reason for caution. If you take any regular medication, have the whole list reviewed by a pharmacist before adding a peptide, not after.
Keep reading
- Peptide therapy at longevity clinics: what is actually prescribed
Approved medicines and unapproved research chemicals, presented as one menu.
- BPC-157: the honest position
Thirty years of animal work and no completed human trial.
- MOTS-c: the mitochondrial peptide with no human data
Why the excitement is fair and the product is not.
- Sermorelin: what's actually approved
A real, discontinued approval — and a thin case for ageing use.
- Best longevity supplements for cellular health and repair
The oral compounds with actual human evidence for cellular energy.
- Free stack check
Screen a proposed protocol against your current medication first.
More in Peptides
- Peptides and therapies commonly used to extend lifespan.
Peptides and adjacent therapies marketed for lifespan extension ranked on human evidence: GLP-1 agonist peptides with outcome trials, growth-hormone-releasing peptides, BPC-157 and other repair peptides, NAD+ infusion therapy, and 'longevity peptide stacks' — with what is actually proven versus what is commonly used.
- What are the safest and best longevity peptides?
Longevity peptides ranked on safety and human evidence together: tesamorelin, PT-141, sermorelin, GHK-Cu, semax and selank, DSIP, then the unregulated injectables — BPC-157, TB-500, MOTS-c, CJC-1295/ipamorelin, epitalon, AOD-9604, melanotan II — with the regulatory status of each.
- Best longevity peptides for anti-aging and cellular repair.
Longevity peptides ranked on their anti-ageing and cellular-repair claims: what each is supposed to repair, what the human evidence shows, and why GHK-Cu on skin outranks every injectable — tesamorelin, BPC-157, TB-500, epitalon, MOTS-c, thymosin alpha-1 and more.
- Which longevity peptides work best for lifespan extension?
Which longevity peptides have any evidence for extending lifespan, ranked honestly: none in humans; the animal data behind epitalon, MOTS-c, SS-31, humanin and the GH-axis peptides; and why the best-evidenced lifespan interventions are not peptides.
- Best longevity peptides for beginners to start with.
Longevity peptides for beginners, ranked on what a first peptide should be — lawful, prescribed, human-studied, low-risk: topical GHK-Cu, then approved peptides via a prescriber, then the grey-market injectables that beginners are usually sold first and should try last, if at all.
- What are the top doctor-recommended longevity peptides?
Doctor-recommended longevity peptides ranked by what the recommendation rests on: guideline-backed prescribing (tesamorelin, bremelanotide), evidence-informed off-label use (sermorelin), and the clinic-menu peptides — BPC-157, TB-500, CJC-1295/ipamorelin — that are recommended commercially and cannot be lawfully compounded.